About Us

The VIVA Foundation is a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education, research, advocacy, and collaboration.

In addition to hosting VIVA (Vascular InterVentional Advances) and The VEINS (Venous Endovascular INterventional Strategies), two annual multidisciplinary vascular education conferences for physicians and healthcare professionals, The VIVA Foundation also presents the Vascular Leaders Forum and collaborates with other industry-leading groups to move the field forward.

AHA-VIVA Research Awards

The VIVA Foundation, in partnership with the American Heart Association, is proud to provide funding opportunities to support early-career scientists pursuing careers in vascular science.

Interested applicants can learn more and apply through the AHA Research Partnerships page for either:

  • AHA Postdoctoral Fellowship (application deadline: September 4)

  • AHA Career Development Award (application deadline: December 2)

For questions, please contact apply@heart.org.

Mission

The VIVA Foundation is committed to:
  • Providing premier education in the fields of vascular medicine and intervention.
  • Improving patient care within the peripheral vascular arena.
  • Advancing the field of vascular medicine with a spirit of collegiality.
  • Promoting research that encourages collaboration and delivers data to improve patient care.
  • Maintaining the highest scientific integrity.

Board of Directors

    Founders

    1. Generic placeholder image

      GARY M. ANSEL, MD

      Interventional Cardiology

      University of Toledo

      Columbus, Ohio

      Pubmed
    2. Generic placeholder image

      MICHAEL D. DAKE, MD

      Interventional Radiology

      The University of Arizona

      Tucson, Arizona

      Pubmed
    3. Generic placeholder image

      TONY S. DAS, MD

      Interventional Cardiology

      Baylor Scott & White Heart Hospital

      Dallas, Texas

      Pubmed
    4. Generic placeholder image

      MICHAEL R. JAFF, DO

      Vascular Medicine

      Harvard Medical School

      Maple Grove, Minnesota

      Pubmed
    5. Generic placeholder image

      JAMES JOYE, DO

      Interventional Cardiology

      Pubmed
    6. Generic placeholder image

      JOHN R. LAIRD JR, MD

      Interventional Cardiology

      Adventist Health St. Helena

      St. Helena, California

      Pubmed
    7. Generic placeholder image

      KRISHNA ROCHA-SINGH, MD

      Interventional Cardiology

      Prairie Heart Institute at St. John's Hospital

      Springfield, Illinois

      Pubmed
    8. Generic placeholder image

      KENNETH ROSENFIELD, MD

      Interventional Cardiology

      Massachusetts General Hospital

      Boston, Massachusetts

      Pubmed
    9. Generic placeholder image

      TIM SULLIVAN, MD

      Vascular Surgery

      Pubmed

      Publications

      • Consensus Statement on the Management of Nonthrombotic Iliac Vein Lesions From the VIVA Foundation, the American Venous Forum, and the American Vein and Lymphatic Society—Circulation: Cardiovascular Interventions, 2024
      • Delphi Consensus on Reporting Standards in Clinical Studies for Endovascular Treatment of Acute Iliofemoral Venous Thrombosis and Chronic Iliofemoral Venous Obstruction—Circulation: Cardiovascular Interventions, 2023
      • Directional Atherectomy Before Paclitaxel Coated Balloon Angioplasty in Complex Femoropopliteal Disease: The VIVA REALITY Study—Catheterization & Cardiovascular Interventions, 2021
      • Mortality and Paclitaxel-Coated Devices: An Individual Patient Data Meta-Analysis—Circulation, 2020
      • Carotid Artery Stenting in Asymptomatic Carotid Artery Stenosis—JACC Journal, 2020
      • Patient-Level Meta-Analysis of 999 Claudicants Undergoing Primary Femoropopliteal Nitinol Stent Implantation—Catheterization and Cardiovascular Interventions, 2017

      Sponsorship and funding for key trials in the vascular field:

      • EMBOLIZE

      • BEST-CLI (NHLBI)

      • BEST Registry (NHLBI)

      • REALITY

      • XCELL

        The Vascular Leaders Forum

        The VIVA Foundation is proud to convene the Vascular Leaders Forum, a multidisciplinary summit that brings together physicians, scientists, members of industry, the FDA, and CMS to address clinical issues in the vascular field. These forums serve to produce white papers that provide direction for these key issues and affect advancement of vascular care.

        By creating forums for dialogue between the clinical vascular community and regulatory agencies, we are working to break down barriers in communication to move the field forward.

        • 2016: CLTI
        • 2018: Carotid Artery Stenting
        • 2019: Paclitaxel Safety
        • 2022: Iliac Vein Stenting & Thrombectomy
        • 2023: NIVL
        • 2024: CLTI

          Where The VIVA Foundation Helps

          In the past several years, The VIVA Foundation has expanded its reach outside of the annual conference by providing charitable contributions to a variety of non-profit organizations including:

          • Americares
          • The American Heart Association - PAD Summit
          • The American Red Cross - Hawaii Wildfires
          • The American Red Cross - Japan Earthquake and Pacific Tsunami
          • Doctors without Borders, USA
          • Feeding America
          • Fibromuscular Dysplasia Society of America
          • Fogarty Institute for Innovation
          • Mercy Corps and Ochsner Clinic Foundation - Hurricane Relief
          • Vascular Disease Foundation
          • World Food Program

          We also offer a unique perspective in clinical trial design and our collaboration with the Food and Drug Administration and other regulatory bodies have been successful in our ongoing desire to increase the quality of patient care.